American Century Companies Inc Dyne Therapeutics, Inc. Transaction History

American Century Companies Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$23.65 - $35.63 $152,566 - $229,849	6,451 New	6,451 $227,000
Q4 2023 Feb 13, 2024	BUY	$6.62 - $13.64 $150,141 - $309,355	22,680 New	22,680 $301,000
Q3 2023 Nov 13, 2023	BUY	$8.6 - $12.18 $63,545 - $89,998	7,389 Added 36.91%	27,407 $245,000
Q2 2023 Aug 14, 2023	BUY	$8.53 - $14.28 $170,753 - $285,857	20,018 New	20,018 $225,000

210

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.55B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.